Clarksville, MD, United States of America

Weiping Yu

This inventor holds 1 USPTO granted patent, plus 2 CIPO patents and 2 EPO patents. Top assignee: Celsion Corporation. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weiping Yu. Retrieved from https://idiyas.com/inventor/weiping-yu-js4qc86y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Weiping Yu: Innovator in Thermosensitive Liposome Technology

Introduction

Weiping Yu is a notable inventor based in Clarksville, MD (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on thermosensitive liposomes.

Latest Patents

Weiping Yu holds a patent for "Thermosensitive liposomes containing therapeutic agents." This invention involves a thermosensitive liposome designed for the effective delivery of active agents. The liposome comprises at least one phosphatidylcholine, at least one phosphatidylglycerol, and at least one lysolipid. Notably, the gel to liquid phase transition temperature of this liposome ranges from 39°C to 45°C. This patent highlights his expertise in creating advanced drug delivery mechanisms.

Career Highlights

Weiping Yu is currently associated with Celsion Corporation, where he continues to develop innovative solutions in the pharmaceutical field. His work focuses on enhancing the efficacy of therapeutic agents through advanced delivery systems.

Collaborations

Weiping Yu collaborates with esteemed colleagues, including Xingguo Mei and Qingwei Jiang, who contribute to his research and development efforts.

Conclusion

Weiping Yu's contributions to thermosensitive liposome technology represent a significant advancement in drug delivery systems. His innovative approach continues to influence the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…